| Prev Close: | 48.23 |
|---|---|
| Open: | 48.04 |
| Bid: | 48.00 x 5000 |
| Ask: | 48.03 x 1600 |
| NAV¹: | 46.27 |
| Net Assets²: | 229.64M |
| YTD Return (Mkt)²: | 18.70% |
| Day's Range: | 47.89 - 48.03 |
|---|---|
| 52wk Range: | 38.32 - 49.03 |
| Volume: | 10,121 |
| Avg Vol (3m): | 61,675 |
| P/E (ttm)²: | 18 |
| Yield (ttm)²: |
¹As of Apr 21, 2013
²As of Aug 30, 2013
Headlines
- [video] Shutdown not huge for biotech: Proat CNBC(Tue, Oct 1)
- [video] Health care technology stock picksat CNBC(Tue, Oct 1)
- September 2013 Distributions for Market Vectors Bank and Brokerage ETF and Market Vectors Pharmaceutical ETFBusiness Wire(Mon, Sep 30)
- [video] NPS Pharma CEO: Do not need to raise cashat CNBC(Wed, Sep 11)
- [video] Seattle Genetics CEO: 7 products being developedat CNBC(Mon, Sep 9)
- [video] Quest for Alzheimer's cureat CNBC(Thu, Sep 5)
- [video] Quintiles CEO: We are confident we're taking shareat CNBC(Mon, Aug 19)
- [video] Stocks & sector time machineat CNBC(Mon, Aug 19)
- [video] Mad Money tweetsat CNBC(Thu, Aug 15)
- [video] Perrigo CEO: Expect $190 million of new product salesat CNBC(Thu, Aug 15)
- [video] ImmunoGen CEO: Toxicity is a normal course for drug developmentat CNBC(Wed, Aug 14)
- [video] Allergan CEO: Botox is performing very wellat CNBC(Thu, Aug 1)
- [video] Obamacare raising cancer care costat CNBC(Wed, Jul 31)
- [video] Big pharma's prescription for profitsat CNBC(Tue, Jul 30)
- [video] Biotech's boom, can it continue?at CNBC(Wed, Jul 24)
Reports
- PHARMACEUTICAL HOLDRS TR (PPH) - REPORT FOR ACTIVE TRADERSPechala's Reports(Sep 30)
- PHARMACEUTICAL HOLDRS TR (PPH) 12-months forecastPechala's Reports(Sep 28)
- "The Economy Matters" Report for PPH: the economy's impact on PPH's price and...MacroRisk Analytics/EconomicInvestor(Sep 25)
